Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hiroya Hayashi

Showing results (31-40 of 47) with videos related to

Pageof 5
Sort By:
Circulation Reports|May 12, 2025
Rationale and Design of an Exploratory, Randomized, Open-Label, Multicenter Clinical Trial to Investigate the Efficacy of Long-Acting β2-Agonist/Long-Acting Muscarinic Antagonist on Heart Failure Complicated by Chronic Obstructive Pulmonary Disease (COPD-HF Trial)Hiroya Hayashi, Shin Ito, Hiroki Fukuda, et al.
The European Respiratory Journal|March 6, 2025
Survival trends in patients with chronic thromboembolic pulmonary hypertension: An observational studyTakatoyo Kiko, Ryotaro Asano, Yusuke Yoshikawa, et al.
Journal of Cardiology|September 12, 2022
Influence of obesity on incidence of thrombosis and disease severity in patients with COVID-19: From the CLOT-COVID studyYoshito Ogihara, Sen Yachi, Makoto Takeyama, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society|June 6, 2022
Therapeutic-Dose vs. Prophylactic-Dose Anticoagulation Therapy for Critically Ill Patients With COVID-19 in a Practice-Based Observational StudyYugo Yamashita, Sen Yachi, Makoto Takeyama, et al.
Circulation Reports|May 23, 2022
D-Dimer Values and Venous Thromboembolism in Patients With COVID-19 in Japan - From the CLOT-COVID StudyNobutaka Ikeda, Sen Yachi, Makoto Takeyama, et al.
Journal of Cardiology|April 17, 2022
The current status of thrombosis and anticoagulation therapy in patients with COVID-19 in Japan: From the CLOT-COVID studyYuji Nishimoto, Sen Yachi, Makoto Takeyama, et al.
Annals of Vascular Diseases|April 17, 2024
Prophylactic Anticoagulation and Thrombosis in Hospitalized Patients with Clinically Stable COVID-19 at Admission: From the Practice-Based Observational StudyYugo Yamashita, Sen Yachi, Makoto Takeyama, et al.
Thrombosis Research|April 7, 2022
Influence of sex on development of thrombosis in patients with COVID-19: From the CLOT-COVID studyYugo Yamashita, Sen Yachi, Makoto Takeyama, et al.
Journal of Atherosclerosis and Thrombosis|July 31, 2022
Significant Impact of Age on Mortality and Non-significant Impact of Age on Thrombosis and Major Bleeding in Patients with COVID-19: From the CLOT-COVID StudyYugo Yamashita, Sen Yachi, Makoto Takeyama, et al.
Journal of Epidemiology|November 13, 2022
Mortality-associated Risk Factors in Hospitalized COVID-19 Patients in Japan: Findings of the CLOT-COVID StudyMakoto Takeyama, Sen Yachi, Yuji Nishimoto, et al.
Pageof 5

Showing results (31-40 of 47) with videos related to

Sort By:
Pageof 5
Circulation Reports|May 12, 2025
Rationale and Design of an Exploratory, Randomized, Open-Label, Multicenter Clinical Trial to Investigate the Efficacy of Long-Acting β2-Agonist/Long-Acting Muscarinic Antagonist on Heart Failure Complicated by Chronic Obstructive Pulmonary Disease (COPD-HF Trial)Hiroya Hayashi, Shin Ito, Hiroki Fukuda, et al.
The European Respiratory Journal|March 6, 2025
Survival trends in patients with chronic thromboembolic pulmonary hypertension: An observational studyTakatoyo Kiko, Ryotaro Asano, Yusuke Yoshikawa, et al.
Journal of Cardiology|September 12, 2022
Influence of obesity on incidence of thrombosis and disease severity in patients with COVID-19: From the CLOT-COVID studyYoshito Ogihara, Sen Yachi, Makoto Takeyama, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society|June 6, 2022
Therapeutic-Dose vs. Prophylactic-Dose Anticoagulation Therapy for Critically Ill Patients With COVID-19 in a Practice-Based Observational StudyYugo Yamashita, Sen Yachi, Makoto Takeyama, et al.
Circulation Reports|May 23, 2022
D-Dimer Values and Venous Thromboembolism in Patients With COVID-19 in Japan - From the CLOT-COVID StudyNobutaka Ikeda, Sen Yachi, Makoto Takeyama, et al.
Journal of Cardiology|April 17, 2022
The current status of thrombosis and anticoagulation therapy in patients with COVID-19 in Japan: From the CLOT-COVID studyYuji Nishimoto, Sen Yachi, Makoto Takeyama, et al.
Annals of Vascular Diseases|April 17, 2024
Prophylactic Anticoagulation and Thrombosis in Hospitalized Patients with Clinically Stable COVID-19 at Admission: From the Practice-Based Observational StudyYugo Yamashita, Sen Yachi, Makoto Takeyama, et al.
Thrombosis Research|April 7, 2022
Influence of sex on development of thrombosis in patients with COVID-19: From the CLOT-COVID studyYugo Yamashita, Sen Yachi, Makoto Takeyama, et al.
Journal of Atherosclerosis and Thrombosis|July 31, 2022
Significant Impact of Age on Mortality and Non-significant Impact of Age on Thrombosis and Major Bleeding in Patients with COVID-19: From the CLOT-COVID StudyYugo Yamashita, Sen Yachi, Makoto Takeyama, et al.
Journal of Epidemiology|November 13, 2022
Mortality-associated Risk Factors in Hospitalized COVID-19 Patients in Japan: Findings of the CLOT-COVID StudyMakoto Takeyama, Sen Yachi, Yuji Nishimoto, et al.
Pageof 5